New generation of lower profile devices were rolled out during the year which further expanded the universe of patients eligible for endovascular repair and the overall market.
According to thought leaders, the years ahead promise to be even more exciting.
Paradigms will be shifted and innovation will accelerate to meet the remaining challenges of the aorta and before the end of the decade close to 90% of aortic aneurysm patients will be treated endovascularly.
Aortic Endografts Market attempts to answer some important questions regarding the fast evolving aortic stent grafts landscape.
The report analyzes revenue and growth trends for the entire market with special emphasis on abdominal, thoracic and fenestrated stent graft segments.
Aortic Endografts Market is targeted at senior executives in the medical device industry who wish to get up-to-date with this two billion dollar fast growing market.
About Medtech Ventures:
Medtech Ventures is a forward looking think tank specialized in the medical technology industry. Medtech Ventures‘s Reports are short insightful quality documents targeted at CEOs, Strategists, Venture Capitalists, and Marketing Directors in the medical technology industry.